Published in Asian J Surg on April 01, 2011
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol (2013) 0.81
Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One (2014) 0.80
Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma. World J Surg Oncol (2013) 0.78
Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV? J Cancer Res Clin Oncol (2016) 0.75
Aggressive resection is indicated for cecal diverticulitis. Am J Surg (2003) 2.17
MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol (2012) 2.03
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res (2012) 1.97
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77
Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies. Am Surg (2004) 1.70
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63
Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol (2003) 1.60
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58
Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56
Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. J Clin Oncol (2013) 1.52
Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg (2004) 1.52
Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol (2011) 1.50
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.49
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol (2002) 1.47
Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.43
Surgical treatment of thyroid cancers with concurrent Graves disease. Ann Surg Oncol (2004) 1.43
Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol (2007) 1.41
Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis (2003) 1.40
Primary angiosarcoma of the spleen. J Surg Oncol (2005) 1.37
Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg (2006) 1.36
Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol (2003) 1.34
Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg (2004) 1.28
Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog (2010) 1.27
New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.23
Management and outcome of bleeding pseudoaneurysm associated with chronic pancreatitis. BMC Gastroenterol (2006) 1.23
Reliability of a new ultrasonic cardiac output monitor in recipients of living donor liver transplantation. Liver Transpl (2008) 1.23
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother (2005) 1.19
Usefulness of multidetector computed tomography for the initial assessment of blunt abdominal trauma patients. World J Surg (2006) 1.18
Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol (2007) 1.16
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery (2009) 1.16
Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol (2006) 1.14
Clinicopathological analysis of cystic duct carcinoma. Hepatogastroenterology (2005) 1.13
Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Ann Surg Oncol (2006) 1.11
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One (2012) 1.10
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09
Perforation through small bowel malignant tumors. J Gastrointest Surg (2005) 1.08
Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg (2003) 1.06
Adenosquamous carcinoma of the pancreas. Digestion (2005) 1.05
Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology (2005) 1.05
Scoring short-term mortality after liver transplantation. Liver Transpl (2010) 1.05
Primary angiosarcoma of the spleen in a child with long-term survival. Pediatr Surg Int (2007) 1.05
Surgical management of gallbladder sarcomatoid carcinoma. World J Gastroenterol (2009) 1.04
Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol (2011) 1.03
Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg (2002) 1.03
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03
Breast metastasis from uterine leiomyosarcoma: a case report. Arch Gynecol Obstet (2002) 1.03
Sonographic features of breast hamartomas. J Ultrasound Med (2007) 1.03
Single-centre results of treatment of retroperitoneal and mesenteric cystic lymphangiomas. Dig Surg (2007) 1.03
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol (2008) 1.03
Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J (2012) 1.02
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer (2009) 1.02
Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. J Surg Oncol (2010) 1.02
Techniques of biliary drainage for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.01
Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol (2009) 1.00
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg (2012) 1.00
Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One (2011) 1.00
Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg (2003) 1.00
ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 0.99
Treatment of endobronchial hemorrhage after blunt chest trauma with extracorporeal membrane oxygenation (ECMO). J Trauma (2008) 0.99
Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol (2002) 0.98
Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Ann Surg Oncol (2011) 0.98
Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg (2004) 0.96
Peritoneal implanted hepatocellular carcinoma with rupture after TACE presented as acute appendicitis. Hepatogastroenterology (2002) 0.96
The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery (2011) 0.95
Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg (2011) 0.95